Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program. (2025). SKIN The Journal of Cutaneous Medicine, 9(4), s583. https://doi.org/10.25251/ed52rz19